Free Trial
NASDAQ:SILO

Silo Pharma (SILO) Stock Price, News & Analysis

Silo Pharma logo
$0.45 -0.04 (-8.84%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$0.41 -0.04 (-8.87%)
As of 06:49 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Silo Pharma Stock (NASDAQ:SILO)

Key Stats

Today's Range
$0.44
$0.48
50-Day Range
$0.45
$1.39
52-Week Range
$0.39
$4.50
Volume
629,202 shs
Average Volume
2.21 million shs
Market Capitalization
$2.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

Silo Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

SILO MarketRank™: 

Silo Pharma scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Silo Pharma.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Silo Pharma is -0.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Silo Pharma is -0.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Silo Pharma has a P/B Ratio of 0.21. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    12.08% of the float of Silo Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Silo Pharma has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Silo Pharma has recently increased by 298.92%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Silo Pharma does not currently pay a dividend.

  • Dividend Growth

    Silo Pharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.08% of the float of Silo Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Silo Pharma has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Silo Pharma has recently increased by 298.92%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Silo Pharma has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Silo Pharma this week, compared to 1 article on an average week.
  • Search Interest

    19 people have searched for SILO on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Silo Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.37% of the stock of Silo Pharma is held by insiders.

  • Percentage Held by Institutions

    Only 5.58% of the stock of Silo Pharma is held by institutions.

  • Read more about Silo Pharma's insider trading history.
Receive SILO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silo Pharma and its competitors with MarketBeat's FREE daily newsletter.

SILO Stock News Headlines

July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are already using to their advantage… It allows them to treat this new asset like actual cash.
See More Headlines

SILO Stock Analysis - Frequently Asked Questions

Silo Pharma's stock was trading at $0.89 at the beginning of the year. Since then, SILO stock has decreased by 49.9% and is now trading at $0.4455.
View the best growth stocks for 2025 here
.

Silo Pharma, Inc. (NASDAQ:SILO) announced its quarterly earnings results on Friday, May, 9th. The company reported ($0.23) EPS for the quarter. The company had revenue of $0.02 million for the quarter. Silo Pharma had a negative net margin of 5,255.05% and a negative trailing twelve-month return on equity of 61.38%.

Shares of SILO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Silo Pharma investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Citius Pharmaceuticals (CTXR), Sunshine Biopharma (SBFM), AbbVie (ABBV) and BioRestorative Therapies (BRTX).

Company Calendar

Last Earnings
5/09/2025
Today
5/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Apparel
Current Symbol
NASDAQ:SILO
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,700,000.00
Net Margins
-5,255.05%
Pretax Margin
-5,157.86%

Debt

Sales & Book Value

Annual Sales
$72,102.00
Price / Cash Flow
N/A
Book Value
$2.14 per share
Price / Book
0.21

Miscellaneous

Free Float
4,288,000
Market Cap
$2.00 million
Optionable
Not Optionable
Beta
0.37
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:SILO) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners